Skip to content
1 Minute Read

Medex Healthcare Research: Reduce 50% of Protocol Deviations

reduce-protocol-deviations-james-greenwald-md

Want to learn how you can mitigate and reduce half of potential protocol deviations?

Medex Healthcare Research uses Clinical Research IO’s intuitive, robust eSource to reduce protocol deviations, thus reducing exposure for their Principal Investigators. An auditor’s review of the system confirmed that the system has safeguards against 50% of the most common audit findings.

Learn how from Dr. Greenwald, Medex Healthcare Research’s PI.

Other Case Studies to Download

CRIO favicon by Team CRIO
Share this case study
You may also find interesting
Explore our Case Studies
Takoda Case Study
Downloadable Materials
1 Minute Read -

CRO uses CRIO eSource to double monitoring productivity

Discover how Takoda Roland, a Clinical Team Manager, used eSource to enable remote monitoring, allowing his phase 3 global trial to not only continue but excel during the COVID-19 pandemic. In this compelling case study, learn how Takoda and his team harnessed the power of CRIO eSource to overcome unprecedented obstacles, boost productivity, and significantly enhance the quality...

Faster data without sacrificing quality
Running a Study
1 Minute Read -

CRIO Provides Data 90% Faster Without Sacrificing Data Quality

In this case study, we explore how a prominent healthcare service provider, overseeing clinical research initiatives on behalf of pharmaceutical clients, leveraged CRIO’s innovative data platform to revolutionize their operations. Faced with the challenge of managing large-scale observational studies efficiently, the client implemented CRIO’s technology, resulting in a remarkable 90% acceleration in data processing speed...

Using CRIO eConsent to Facilitate a 200% Increase in Enrollment
1 Minute Read -

Using eConsent to Facilitate a 200% Increase in Enrollment

Innovo Research adopts eConsent to Improve Research Enrollment and Value-Based Care Delivery Innovo Research, Inc. is running several cancer screening studies for high-risk patients that involve biospecimen collection. As a research partner to health care organizations that operate within value-based care delivery frameworks, Innovo views these studies as valuable contributions to research, as well as...

Get articles delivered to your inbox, every week